BacLite Rapid MRSA Clinical Performance
Data Collection
Collected from today forward - ProspectiveSummary
Study start date: October 1, 2007
Actual date on which the first participant was enrolled.The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * Subjects 18 years or older * Subjects willing to document demographic characteristics * Subjects willing to have their nose swabbed * Subjects (or legal representative) willing to sign consent and authorization forms Exclusion Criteria: * Subjects who use Vicks Sinex Nasal spray or other nasal sprays * Subjects with prescribed nasal medical devices where collecting samples may resent more than minimal risk to subjects * Subjects having nasal prosthetics, jewelry or trauma to the nose or anything that may prevents sampling the anterior nares * Investigator believes that subject is unsuitable for inclusion.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 9 locations
Atlanta Institute for Medical Research, Inc.
Atlanta, United StatesEvanston Northwestern Healthcare
Evanston, United StatesUniversity of Iowa
Iowa City, United States